Category
blog
-
2023
-
Idorsia Urges DEA to Deschedule Chronic Insomnia Drug Class
-
Drugmakers sign letter supporting FDA and calling for reversal of Texas judge’s mifepristone drug ruling
-
Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall
-
Novo Nordisk and Aspect Biosystems partner in billion dollar deal for diabetes treatments
-
Biogen to develop amyloid beta-targeting antibody platform
-
Sumitomo Pharma’s Ewing Sarcoma Candidate Gains Orphan Drug Status
-
PROTAC. Protein degradation (PROTAC and beyond)
-
Medicinal chemistry FTE
-
Save to Wish Lists CXCR4-Targeted Library
-
The FDA Commissioner Who Approved the Abortion Pill Is Still Fighting for It